Molecular pathology as basis for timely cancer diagnosis and therapy

A. Craig Mackinnon, Darshan Shimoga Chandrashekar, David I. Suster

Research output: Contribution to journalReview articlepeer-review

Abstract

Precision and personalized therapeutics have witnessed significant advancements in technology, revolutionizing the capabilities of laboratories to generate vast amounts of genetic data. Coupled with computational resources for analysis and interpretation, and integrated with various other types of data, including genomic data, electronic medical health (EMH) data, and clinical knowledge, these advancements support optimized health decisions. Among these technologies, next-generation sequencing (NGS) stands out as a transformative tool in the field of cancer treatment, playing a crucial role in precision oncology. NGS-based workflows are employed across a range of applications, including gene panels, exome sequencing, and whole-genome sequencing, supporting comprehensive analysis of the entire cancer genome, including mutations, copy number variations, gene expression profiles, and epigenetic modifications. By utilizing the power of NGS, these workflows contribute to enhancing our understanding of disease mechanisms, diagnosis confirmation, identifying therapeutic targets, and guiding personalized treatment decisions. This manuscript explores the diverse applications of NGS in cancer treatment, highlighting its significance in guiding diagnosis and treatment decisions, identifying therapeutic targets, monitoring disease progression, and improving patient outcomes.

Original languageEnglish
JournalVirchows Archiv
DOIs
StateAccepted/In press - 2023
Externally publishedYes

Keywords

  • Electronic medical health
  • Molecular pathology
  • Next-generation sequencing

Fingerprint

Dive into the research topics of 'Molecular pathology as basis for timely cancer diagnosis and therapy'. Together they form a unique fingerprint.

Cite this